IMPALA-linked presenters and moderators at The 2020 Union Conference

Oral presentations

Union Code

Session Title

Abstract Title

Name

Description

Location

Date/time

OA-03

Optimising lung health beyond TB

How does exposure to fine particulate matter in Malawi vary by gender, exposure source and cooking characteristics? Fine grain data from an ethnography-linked exposure study

Sepeedeh Saleh

Air pollution exposure through the life course contributes to a range of respiratory pathology in adults and children. In Malawi a great majority of the population use solid fuels for cooking, causing frequent exposure to high concentrations of air pollution including fine particulate matter (PM2.5). We use preliminary air quality data from a mixed methods ethnographic study of air pollution in a Malawian village to describe PM2.5 exposures by gender, exposure source and cooking features in this setting. 

Channel 3

21/10/20

11:37 - 11:45

OA-03

Optimising lung health beyond TB

Availability of diagnostic services and essential medicines for non-communicable respiratory diseases in African counties 

Catherine Plum

The study aimed to explore the availability of diagnostic spirometry and essential medicines for asthma and COPD in African countries. Data was collected by a questionnaire given to attendees at PATS MECOR and IMPALA meeting. Primary data on availability was gathered and reasons behind the challenges of non-availability were explored.

Channel 3

21/10/20

11:53 - 12:01

OA-03

Optimising lung health beyond TB

Chronic Lung Diseases Remain Under-Prioritized in Africa Despite Their Growing Burden: Findings from a Lung Health Policy Analysis

Emma Heneine

Despite the growing burden of chronic lung diseases (CLDs) in Africa, investment in research, policy and programmes is lacking. Understanding regional and national-level lung health policy environments (via policy desk review and key informant interviews) is critical to inform generation, and effective, uptake of relevant and responsive lung health research.

Channel 3

21/10/20

12:01 - 12:09

SP-11

Treating Mild Asthma: A Paradigm Shift

Combination inhaler (ICS/ formoterol) Applicability to children: A Low resource setting perspective.

Refiloe Masekela

Asthma in children is increasing in prevalence in children in low middle-income countries. Risk factors for this increase and poor asthma control in this population are poorly studied. One of the critical gaps in asthma treatment is access to affordable and safe medication delivered via an appropriate delivery system. The current GINA recommendations encourage the use of combination therapy to improve asthma control, but this may not be possible in settings where there is poor access to spacer delivery systems and unaffordability of drugs. Motivation for one drug device to manage asthma is an attractive option in this setting where there is an overuse of short-acting beta-agonist, together with interventions and advocacy to improve access to asthma treatment may be a solution to this issue in low-income settings

Channel 3

21/10/20

16:59-17:11

SP-38

Hidden, but for how much longer? The epidemiological and economic burden of post-TB

Post-TB lung disease at the bedside

Brian Allwood

This talk will begin with the definition of post-tuberculosis lung disease (PTLD), highlighting the strengths and limitations of the currently proposed definition. It will then describe a clinical classification of PTLD and explain areas of complexity, which can hamper measurement of PTLD, using single instruments (e.g. spirometry alone). The talk will use case studies of patients with PTLD as illustrations suitable for both non-clinicians and clinicians not familiar with the management of PTLD. Difficulties in clinical management of such patients will be briefly mentioned.

Channel 4

23/10/20

16:35-16:45

OA-40

Health and well-being post TB

 

Lung function post-TB in Malawian adults: a three-year cohort study   Rebecca Nightingale  We followed-up patients three years from complication of tuberculosis (TB) treatment and reviewed patient outcomes including lung function, healthcare-seeking, symptoms and clinical observation. We concluded that, for a subset of the population, post-TB lung disease is a significant consequence of pulmonary TB.  Channel 2  

24/10/20

16:35-16:45

Poster presentation

Union Code

Session Title

Abstract Title

Name

Description                                                             Location

Date/time

 

EP25

Lung health across the lifespan

It’s not TB but what could it be? Abnormalities on chest X-rays from the 2016 Kenya National Tuberculosis Prevalence Survey

Brenda Mungai

All E-posters will be accessible online starting at 10:00 am (Central European time) on the allocated date

E-poster area

23/10/20

All day from 10am

Moderating

 

Session Title

Name

Location

Description

Date/time

OA-03

Optimising lung health beyond TB

Rebecca Nantanda

Channel 3

Tracks: Epidemiology, Clinical and Operational Research

21/10/20

11:00 - 12:20

OA-03

Optimising lung health beyond TB

Jamie Rylance

Channel 3

Tracks: Epidemiology, Clinical and Operational Research

21/10/20

11:00 - 12:20

SP-11

Treating Mild Asthma: A Paradigm Shift

Asma El Sony

Channel 3

Management of mild asthma has for a long time been unsatisfactory and the treatment of mild asthma has not been tested in clinical trials. The use/overuse of short-acting beta-2 agonist (SABA) alone in patients treated as mild asthmatics has become a concern and the association with severe adverse events has become clear. Access adherence with regular inhaled corticosteroid (ICS) treatment is a major issue in this population. The rationale efficacy of treatment with as needed ICS and rapid acting bronchodilator will be discussed in this session.

21/10/20

16:30-17:50

OA-29

Who pays the cheque? The economic burden of TB

Bertie Squire

Channel 3

Tracks: Health Economics, Access to quality TB care and services

23/10/20

15:00-16:20

P4

Plenary 4: Greed, smoke and lung health

Asma El Sony

Channel 1

Session description: The adverse impact of natural disasters, practices such as deforestation and agricultural burning and man-made products such as tobacco and nicotine on environmental determinants of health, such as clean air, cannot be ignored. And yet, industries profiting from these practices and products continue business as usual with minimal consideration of these problems. “Reduced Risk Products” are presented as safer alternatives to cigarettes. Ineffective and insufficient methods to mitigate climate crisis are proposed – delaying meaningful action. The fight for lung health must include addressing these major contributors to lung health issues in an effective manner, to protect the health of all people, in particular the most vulnerable.

24/10/20

14:00-15:00

OA-40

Health and well-being post TB

Jamilah Meghji

Channel 2

Tracks: Post-TB Lung Health

24/10/2020

15:00-16:20